Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer
This study is to evaluate the safety of SU011248 in combination with paclitaxel in patients with metastatic or locally recurrent breast cancer who have not received chemotherapy treatment in the advanced disease setting.
Breast Neoplasms
DRUG: SU011248|DRUG: Paclitaxel
Safety of the combination of SU011248 and paclitaxel, 9/05-7/07
Pharmacokinetics of each medication, 9/05-7/07|Objective disease response, 9/05-7/07|Progression-free survival., 9/05-7/07
This study is to evaluate the safety of SU011248 in combination with paclitaxel in patients with metastatic or locally recurrent breast cancer who have not received chemotherapy treatment in the advanced disease setting.